STAAR Surgical (NASDAQ: STAA) reported Q2 EPS of $0.08, $0.04 better than the analyst estimate of $0.04. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Earnings Management Comments

STAAR Surgical Announces Submission of Presbyopia Clinical Trial Data; Proprietary EDOF Collamer® Lens is Designed to Improve Near, Intermediate and Distance VisionJuly 31, 2019 4:10 PM STAAR Surgical Reports Record Second Quarter Results for Total Revenue, ICL Sales and ICL UnitsJuly 31, 2019 4:01 PM